Logo image of ALVER.PA

VERGNET (ALVER.PA) Stock Fundamental Analysis

EPA:ALVER - FR001400JXA2 - Common Stock

0.0004 EUR
0 (-20%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALVER. ALVER was compared to 58 industry peers in the Electrical Equipment industry. ALVER has a bad profitability rating. Also its financial health evaluation is rather negative. ALVER has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ALVER has reported negative net income.
ALVER had a negative operating cash flow in the past year.
ALVER had negative earnings in 4 of the past 5 years.
In the past 5 years ALVER always reported negative operating cash flow.
ALVER.PA Yearly Net Income VS EBIT VS OCF VS FCFALVER.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5M -10M -15M -20M

1.2 Ratios

The Return On Assets of ALVER (-17.00%) is worse than 82.76% of its industry peers.
Industry RankSector Rank
ROA -17%
ROE N/A
ROIC N/A
ROA(3y)-37.24%
ROA(5y)-23.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALVER.PA Yearly ROA, ROE, ROICALVER.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600 -800

1.3 Margins

The Gross Margin of ALVER (57.07%) is better than 84.48% of its industry peers.
ALVER's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALVER so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 57.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-6.32%
ALVER.PA Yearly Profit, Operating, Gross MarginsALVER.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

0

2. Health

2.1 Basic Checks

ALVER does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALVER has more shares outstanding
Compared to 5 years ago, ALVER has more shares outstanding
Compared to 1 year ago, ALVER has an improved debt to assets ratio.
ALVER.PA Yearly Shares OutstandingALVER.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
ALVER.PA Yearly Total Debt VS Total AssetsALVER.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

ALVER has an Altman-Z score of -1.37. This is a bad value and indicates that ALVER is not financially healthy and even has some risk of bankruptcy.
ALVER has a Altman-Z score of -1.37. This is amonst the worse of the industry: ALVER underperforms 87.93% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.37
ROIC/WACCN/A
WACC6.25%
ALVER.PA Yearly LT Debt VS Equity VS FCFALVER.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M

2.3 Liquidity

ALVER has a Current Ratio of 0.88. This is a bad value and indicates that ALVER is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.88, ALVER is doing worse than 87.93% of the companies in the same industry.
ALVER has a Quick Ratio of 0.88. This is a bad value and indicates that ALVER is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.77, ALVER is doing worse than 67.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.77
ALVER.PA Yearly Current Assets VS Current LiabilitesALVER.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
ALVER shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -31.06%.
ALVER shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.95% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-31.06%
Revenue growth 3YN/A
Revenue growth 5Y3.95%
Sales Q2Q%-47.37%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALVER.PA Yearly Revenue VS EstimatesALVER.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2023 10M 20M 30M 40M

0

4. Valuation

4.1 Price/Earnings Ratio

ALVER reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALVER.PA Price Earnings VS Forward Price EarningsALVER.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALVER.PA Per share dataALVER.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6 -8 -10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for ALVER!.
Industry RankSector Rank
Dividend Yield N/A

VERGNET

EPA:ALVER (9/4/2025, 7:00:00 PM)

0.0004

0 (-20%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.81M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-11.99
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0
BVpS0
TBVpS0
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 57.07%
FCFM N/A
ROA(3y)-37.24%
ROA(5y)-23.38%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-6.32%
F-Score3
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -46.36%
Cap/Sales 2.94%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.77
Altman-Z -1.37
F-Score3
WACC6.25%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-31.06%
Revenue growth 3YN/A
Revenue growth 5Y3.95%
Sales Q2Q%-47.37%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.49%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1472.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5440.83%
OCF growth 3YN/A
OCF growth 5YN/A